Dr Amy Lucas, a gastroenterologist from Mt Sinai in NYC and Maureen Mork, a senior genetic counselor at MD Anderson Cancer Center in Houston are leading a discussion on managing hereditary cancer risk during the challenges of the COVID crisis

Poll of hereditary cancer provide’s concerns during COVID — we are very concerned about delays in our patients care!

Great #CGAIGC20 Rising Stars talk from Sanne Bajwa - ten Broeke discussing possible explanations for the CRC risk variability across different types of #Lynchsyndrome. 100% agree: "It's important to include the specific MMR gene in the description of Lynch syndrome patients."

Dr Steve Gruber, the 2020 Vogelstein Lectureship speaker from USC is discussing the incredible contribution of the Bert Vogelstein “family tree” on precision medicine and the specific impact of hereditary risk and germ line genetics on treatment of cancer #CGAIGC20

Dr Steve Gruber @ Vogelstein lecture discusses findings published by Samadder et at in JAMAOnc 2020 that universal genetic testing of unselected adult oncology patients captures more actionable mutations than a guideline-based approach w/30% gaining treatment options #CGAIGC2020

Dr. Gruber states, from some of his own research “Aspirin and statins unequivocally modify the host immune response” in cancer patients with compelling data to be presented at AACR 2021.

Save the date for 2021 CGA-IGC #CGAIGC20 . Either virtual or in person, highly recommended for people working on gastrointestinal cancer predisposition.

📢 General session IV CGA-IGC Rising Stars in Inherited GI Cancers with Greg Idos City of Hope Discussing 4 great abstracts in Familial Pancreatic Cancer/RABL3, PMS2 variants in #LynchSd, MUYTH novel functional variants, CTNN1 Sahar Nissim, MD, PhD Sanne Bajwa - ten Broeke #CGAIGC20

Proposed polyp growth model in #FAP being discussed by Ed Esplin, MD, PhD for the #CGAIGC20 Presidential Plenary Abstract Session.

The Philly Incredibowels are stomping out the competition in their quest to raise money for hereditary GI cancer research on behalf of the CGA-IGC Virtual Fun(d)Run 2020! Thanks for your support! Donate at givebutter.com. #CGAIGC2020

Recognizing Lynch Syndrome Awareness Day: MARCH 22, 2021. Lynch syndrome affects 1/280 people and puts them at increased risk of developing cancer. Most people affected by LS don’t even know they have it and are unaware of the many prevention options available to them.

From the April issue: Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated (ATM) Gene are Associated with High and Moderate Risks for Multiple Cancers. Allison Kurian Michael J Hall bit.ly/3cNEHyn

Clinical trial aims to improve treatment for early-stage #colorectalcancer @foxchasecancer 6abc.com/health/clinica… via Action News on 6abc Namrata (Neena) Vijayvergia MD Get Your Rear in Gear Philadelphia #organpreservation

🙏Get Your Rear in Gear Philadelphia for supporting our new #colorectal clinical trial Fox Chase Cancer Center Temple Health News Colon Cancer Coalition Efrat Dotan MD National Comprehensive Cancer Network (NCCN) ASCO Society of Surgical Oncology ACS Cancer Programs

Had the most incredible time this weekend at #LMSANE2023. Never felt more at home in medicine! Looking forward to the national conference this Fall! LMSA Northeast LMSA National

Ed Esplin, MD, PhD Zsofia Stadler Memorial Sloan Kettering Cancer Center ASCO How about germline genetics testing for all cancer patients, period?

Kurian et al presentation conclusions #ASCO23: Genetic testing use fell well below recommended guidelines from 2013-2121. 😞 Male breast 50% Ovarian 39% Pancreatic 6% (100% is Recommend)😳 Complete data published in JAMA today. Congrats to all authors! Myriad Genetics

Dr Olopade discussing the Myriad Genetics combined PRS with TC 8 for ALL ancestries stratifies breast cancer risk beyond clinical factors currently used in the clinic. #ASCO23